The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures

Afr Health Sci. 2021 Jun;21(2):628-632. doi: 10.4314/ahs.v21i2.18.

Abstract

Background: Tuberculosis (TB) sputum culture contaminants make it difficult to obtain pure TB isolates.We aimed to study and identify persistent TB sputum culture contaminants post the standard laboratory pre-culture sample decontamination techniques.

Methods: This was a longitudinal study of TB sputum culture contamination for a cohort of TB patients on standard treatment at: baseline, during TB treatment and post TB treatment. Sputum samples were decontaminated with 1.5%NaOH and neutralized using 6.8 Phosphate buffer solution.Sputum was then inoculated into MGIT (mycobactrial growth indicator tube) supplemented with 0.8ml PANTA. A drop of each positive MGIT culture was sub cultured onto blood agar and incubated for 48 hours at 35 -37OC.Any growth was identified using growth characteristics and colony morphology.

Results: From October 2017 through May 2019;we collected 8645 sputum samples of which 8624(99.8%) were eligible and inoculated into MGIT where 2444(28.3%)samples were TB culture positive and 255(10.4%)were positive for contaminants: 237 none-tuberculosis bacteria, 12 fungi and 6 mixed(none-tuberculous bacteria+fungi). There was no statistically significant difference between none tuberculosis bacteria and fungi in the treatment (OR=1.4,95%CI:0.26-7.47,p=0.690) and the post treatment TB phases(OR=2.02,95%CI:0.38-10.79,p=0.411)Vs baseline.

Conclusion: None-tuberculous bacteria and fungi dominate the plethora of TB sputum culture contamination and persist beyond the standard laboratory pre-culture decontamination algorithm.

Keywords: Bacteria; Fungi; Inoculation; PANTA (Polymyxin B, Amphotericin B, Nalidixic acid, Trimethoprim, Azlocillin).

MeSH terms

  • Amphotericin B / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Azlocillin / pharmacology
  • Bacteria / isolation & purification
  • Bacteriological Techniques / methods*
  • Bacteriological Techniques / standards
  • Fungi / isolation & purification
  • Humans
  • Longitudinal Studies
  • Mycobacterium tuberculosis / growth & development
  • Nalidixic Acid / pharmacology
  • Polymyxin B / pharmacology
  • Sputum / microbiology*
  • Trimethoprim / pharmacology
  • Tuberculosis / diagnosis*

Substances

  • Anti-Bacterial Agents
  • Nalidixic Acid
  • Amphotericin B
  • Trimethoprim
  • Azlocillin
  • Polymyxin B